A Multicenter, Single arm, Open Label Clinical Trial to Evaluate the Safety and Health-Related Quality of Life of Aflibercept in Patients with Metastatic Colorectal Cancer (mCRC) Previously Treated with an Oxaliplatin-Containing Regimen
(Darmkrebs, Rektumkarzinom, Rektosigmoid, Colon, Rektum, Sigmoideum, Dickdarm, Dickdarmkrebs, Mastdarm)